Latest Asx News

Bio-Gene Technology Limited has been awarded two U.S. Department of Defense grants totaling A$3 million to develop innovative insect control products targeting military and civilian markets.

Neurizon Therapeutics reports encouraging 8-month interim results for its ALS drug NUZ-001, secures Orphan Medicinal Product Designation in Europe, and raises $885,000 through a share placement, maintaining a robust $14 million cash position.

Terra Metals has secured an option to acquire a large tenement package adjacent to its flagship Dante Project, significantly expanding its exploration potential in Western Australia's West Musgrave region.

Strategic Energy Resources has completed a significant 25-hole drill program at its Achilles 1 Prospect, confirming widespread polymetallic mineralisation, while a new electromagnetic survey at its Mundi Project reveals promising conductors for further exploration.

Austin Metals Limited has reported multiple high-grade gold intercepts from recent drilling at its Austin Gold Project, confirming the potential for a large-scale gold system at the Brunswick Hill and Mt Sandy prospects.

BCI Minerals reports robust progress in its Mardie Salt and Potash Project, achieving financial close on a $981 million debt facility and advancing construction beyond the halfway mark. The company maintains a strong focus on sustainability and safety as it targets first salt shipment in Q2 FY27.

Galan Lithium Limited has announced a substantial 150% increase in its Candelas Mineral Resource to 1.6 Mt LCE, lifting its total Hombre Muerto West resource to 9.5 Mt LCE and securing a spot among the world’s top 10 lithium projects.

White Cliff Minerals has secured all necessary permits to initiate drilling at its Rae Copper Project in Nunavut, targeting exceptionally high-grade copper zones identified in 2024. Drilling is set to commence in March 2025, focusing on the Hulk and Danvers prospects.

Holista Colltech Limited reports a notable financial recovery in 4QFY24, underpinned by strong cash inflows and a rebound in its Food Ingredients division, alongside a leadership change aimed at steering future growth.

Waratah Minerals has reported significant progress in its Spur Gold-Copper Project, extending gold zones with over 4,700 metres drilled in the December quarter. Strategic board appointments signal a new phase for the company as it positions itself for further exploration success.

Algorae Pharmaceuticals reports robust progress in its drug development pipeline, highlighted by promising preclinical results for cardiovascular and dementia candidates and significant AI platform enhancements.

CurveBeam AI has reported a record quarter for HiRise™ device purchase orders, driven by a strategic expansion with Stryker in Australia and New Zealand. The company also advanced its FDA regulatory pathway for its BMD module, setting sights on mid-2025 submission.